Table 2.
Associations between keloids, hypertrophic scars, and fibroid incidence among 1,230 participants in the Study of Environment, Lifestyle & Fibroids (SELF), Detroit, Michigan, 2010–2018.
| Hazard ratio (95% confidence interval) | |||||
|---|---|---|---|---|---|
| Exposure category | No. exposed (n = 1,230) | Incident cases (n = 293) | Person-years (n = 5,312) | Minimally adjusteda | Fully adjustedb |
| Keloid scar | |||||
| No | 1031 | 242 | 4432 | Referent | Referent |
| Yes | 199 | 51 | 880 | 1.03 (0.77, 1.39) | 1.04 (0.77, 1.40) |
| Any abnormal scarringc | |||||
| No | 652 | 147 | 2807 | Referent | Referent |
| Yes | 578 | 146 | 2505 | 1.08 (0.86, 1.35) | 1.10 (0.88, 1.38) |
Cox model with age as the time scale with no further covariate adjustment.
Cox model with age as the time scale further adjusted for age at menarche (≤10, 11, 12, 13, or ≥14 years), and time-varying parity (0, 1–2, or ≥3 births), years since last birth (<3 or ≥3 years ago including no births), years since last use of injection contraceptive (<2 or ≥2 years including never), household income (<$20,000 or ≥$20,000 per year), current smoker (no or yes), and body mass index (<30.0, 30.0-<35.0, 35.0-<40.0, or ≥40.0 kg/m2).
Report of either keloid or hypertrophic scar.